跳至主要内容
临床试验/NCT02080936
NCT02080936已完成不适用

Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD

5 Santé1 个研究点 分布在 1 个国家目标入组 138 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
138
试验地点
1
主要终点
Muscle wasting in COPD patient

研究概览

简要总结

Peripheral muscle mass and strength are relevant indicators of COPD survival. Current guidelines recommend to assess muscle strength only in muscle wasted patients. However, a recent study reported quadriceps weakness without muscle wasting (Menon, M et al. Resp. Res.2012, 13:119). Thus, these guidelines raise the risk to miss out some weak patients. In clinical settings, fat-free-mass index (FFMI) is indicated as a simple index to assess muscle wasting. We aimed at determining the prevalence of patients entering in pulmonary rehabilitation (PR) a priori not eligible for muscle strength evaluation given the lack of muscle wasting clinical signs.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients who have got FFMI (bioimpedance)
  • Patients who have done quadriceps muscle strenght evaluation

排除标准

  • Patients without FFMI
  • Patients without quadriceps muscle strenght

结局指标

主要结局

Muscle wasting in COPD patient

时间窗: baseline

次要结局

  • Muscle weakness in COPD patient(baseline)

研究者

发起方
5 Santé
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验